Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07036952 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome.

StatusEnrolling by Invitation
PhaseNot applicable
Started2025-04-22
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 24, 2025 (before its estimated October 30, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2025-07-22
Not Yet Recruiting→Enrolling by Invitation Study Status, Study Design, Arms and Interventions, Outcome Measures, Contacts/Locations v2
Trial statusNot Yet Recruiting→Enrolling by Invitation
PhasePhase 2→Not applicable
Primary completion date2025-11-30→2025-10-30
Start dateestimated 2025-07-01→confirmed 2025-04-22
InterventionsOmega-3 Fatty Acids (Drug)→Omega -3 fatty acids (Drug), Omega 3 fatty acids (Drug)
Primary endpoints2 to 1 entries
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
2025-06-29
Study Identification, Study Status, IPDSharing v1
Study title-52 characters
Effect of Omega-3 Supplementation as Add on Therapy on Metabolic Syndrome in Women With Polycystic Ovary Syndrome: A Randomized Double-Blind, Placebo-Controlled Trial.
2025-06-24
Original filing
The goal of this clinical trial is to learn if Omega-3 works to treat Polycystic ovary syndrome in women. It will also learn about the safety of drug Omega-3. The main questions it aims to answer are: Does Omega-3 lower the number of times participant to treat metabolic syndrome What medical problems do participants have when taking drug Omega-3.Researchers will compare drug Omega-3 to a placebo (a look-alike substance that contains no drug) to see if drug Omega-3 used to treat PCOS. Participants will: Take Omega-3 or a placebo every day for 3 months Visit the clinic once every 6 weeks for checkups and tests Keep a diary of their symptoms and menstrual history.
Trial Details
NCT Number NCT07036952
Lead Sponsor Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Conditions PCOS (Polycystic Ovary Syndrome)
Enrollment 68 participants
Start Date 2025-04-22
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-07-24